ISSN 2149-2263 | E-ISSN 2149-2271
The Anatolian Journal of Cardiology
Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease [Anatol J Cardiol]
Anatol J Cardiol. 2023; 27(1): 54-55 | DOI: 10.14744/AnatolJCardiol.2022.2333

Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease

Anetta Undas
Department of Thromboembolic Diseases, Institute of Cardiology, Jagiellonian University Medical College, Kraków, Poland; Center for Research and Innovative Technology John Paul II Hospital, Kraków, Poland


Anetta Undas. Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease. Anatol J Cardiol. 2023; 27(1): 54-55

Corresponding Author: Anetta Undas
Manuscript Language: English


Journal Metrics

Journal Citation Indicator: 0.18
CiteScore: 1.1
Source Normalized Impact
per Paper:
0.22
SCImago Journal Rank: 0.348

Quick Search



Copyright © 2023 The Anatolian Journal of Cardiology



Kare Publishing is a subsidiary of Kare Media.